APRIL BRITTAIN: Open Payments
NPI 1518208602 · MANASSAS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$941 in 21 payments from 7 companies in 2025. Trend: 2023 $542 · 2024 $666 · 2025 $941
Food & beverage: $885Education: $56
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 11 | $415 |
| GENZYME CORPORATION | 5 | $235 |
| Aimmune Therapeutics, Inc. | 1 | $110 |
| Axsome Therapeutics, Inc. | 1 | $105 |
| Inspire Medical Systems, Inc. | 1 | $32 |
| HARMONY BIOSCIENCES LLC | 1 | $25 |
| Stryker Corporation | 1 | $20 |
Products named: DUPIXENT, ZENPEP, Auvelity, INSPIRE, WAKIX, SCOPIS ENT.
Industry payments across VA — which companies pay providers there.
